Long-acting insulin analogue therapy initiation and follow-up by healthcare practitioners in patients with type 2 diabetes mellitus uncontrolled with oral antidiabetic drugs: the LIGHT Study

被引：0
|
作者：
Verges, B. [1 ]
Brun, J. -M. [1 ]
Tawil, C.
Alexandre, B. [2 ]
Kerlan, V. [3 ]
机构：
[1] CHU Dijon, Hop Bocage, Serv Endocrinol, Paris, France
[2] Novo Nordisk Pharmaceut, Med Affairs, Paris, France
[3] CHU La Cavale Blanche, Brest, France
来源：
DIABETOLOGIA | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
972
引用
收藏
页码：S382 / S382
页数：1
相关论文
共 50 条
  • [11] Evaluation of the effectiveness of long-acting insulin analogs in patients with type 2 diabetes mellitus
    Tuba Taslamacioglu Duman
    Gulali Aktas
    Burcin Meryem Atak Tel
    Satilmis Bilgin
    Gizem Kahveci
    Ozge Kurtkulagi
    Journal of Public Health, 2023, 31 : 2039 - 2044
  • [12] Insulin Degludec, a Long-Acting Once-Daily Basal Analogue for Type 1 and Type 2 Diabetes Mellitus
    Berard, Lori
    MacNeill, Gail
    CANADIAN JOURNAL OF DIABETES, 2015, 39 (01) : 4 - 9
  • [13] Effect of Dulaglutide and Long-Acting Insulin Combination Therapy in Patients with Type 2 Diabetes
    Ito, Kohei
    Kondo, Yoshinobu
    Satoh, Shinobu
    Terauchi, Yasuo
    DIABETES, 2018, 67
  • [14] PROGRANULIN AND CHEMERIN PLASMA LEVEL IN OBESE PATIENTS WITH TYPE 2 DIABETES TREATED WITH A LONG-ACTING INSULIN ANALOGUE AND PREMIXED INSULIN ANALOGUE
    Waluga-Kozlowska, E.
    Kuznik-Trocha, K.
    Komosinska-Vassev, K.
    Olczyk, P.
    Jura-Poltorak, A.
    Winsz-Szczotka, K.
    Telega, A.
    Ivanova, D.
    Strzoda, W.
    Zimmermann, A.
    Janik, M.
    Olczyk, K.
    Waluga, M.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2021, 72 (06): : 895 - 903
  • [15] The Use of Long-Acting Insulin Analogues and the Risk of Colorectal Cancer in Patients with Type 2 Diabetes Mellitus
    Pradhan, Richeek
    Yin, Hui
    Yu, Oriana HoiYun
    Azoulay, Laurent
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 52 - 52
  • [16] Effect of dulaglutide and long-acting insulin combination therapy in patients with type 2 diabetes: a retrospective observational study
    Kohei Ito
    Shinobu Satoh
    Yoshinobu Kondo
    Haruka Tamura
    Masanori Hasebe
    Yasuo Terauchi
    Diabetology International, 2023, 14 : 51 - 57
  • [17] Willingness to Pay for Improvements in Chronic Long-Acting Insulin Therapy in Individuals With Type 1 or Type 2 Diabetes Mellitus
    Lloyd, Andrew
    Nafees, Beenish
    Barnett, Anthony H.
    Heller, Simon
    Ploug, Uffe J.
    Lammert, Morten
    Bogelund, Mette
    CLINICAL THERAPEUTICS, 2011, 33 (09) : 1258 - 1267
  • [18] Effect of dulaglutide and long-acting insulin combination therapy in patients with type 2 diabetes: a retrospective observational study
    Ito, Kohei
    Satoh, Shinobu
    Kondo, Yoshinobu
    Tamura, Haruka
    Hasebe, Masanori
    Terauchi, Yasuo
    DIABETOLOGY INTERNATIONAL, 2023, 14 (01) : 51 - 57
  • [19] Usefulness of the long-acting insulin analogue glargine in basal-bolus therapy for Japanese children and adolescents with type 1 diabetes Mellitus
    Urakami, T.
    Morimoto, S.
    Kubota, S.
    Funaki, S.
    Harada, K.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2007, 20 (07): : 807 - 815
  • [20] Insulin initiation in primary care for patients with type 2 diabetes: 3-Year follow-up study
    Dale, Jeremy
    Martin, Steven
    Gadsby, Roger
    PRIMARY CARE DIABETES, 2010, 4 (02) : 85 - 89
12345